|
|||||
|
|

Personal care company Edgewell Personal Care (NYSE:EPC) announced better-than-expected revenue in Q3 CY2025, with sales up 3.8% year on year to $537.2 million. Its non-GAAP profit of $0.68 per share was 15.6% below analysts’ consensus estimates.
Is now the time to buy EPC? Find out in our full research report (it’s free for active Edge members).
Edgewell Personal Care’s third quarter results reflected solid top-line momentum, with organic net sales growth driven by international markets and modest recovery in core North America segments. Management highlighted that improved market share in key brands and categories, together with ongoing innovation and supply chain productivity efforts, helped offset weaker performance in sun care and tariff-related cost pressures. CEO Rod Little acknowledged the external and internal challenges faced during the quarter, stating, “We faced significant external pressures: tariffs, foreign exchange volatility, geopolitical tensions, and consumer uncertainty that impacted our financial performance and stressed our global supply chain.”
Looking forward, Edgewell’s guidance is shaped by a transition year focused on stabilizing North America, investing in core brands, and navigating ongoing tariff and promotional headwinds. Management expects international markets to remain the growth engine, with brand investments and supply chain optimization positioned to support gradual margin recovery. CFO Fran Weissman noted, “Our expectations include a return to organic top-line growth, gross margin accretion, as well as a step up in investments through higher A&P spend, where we are leaning into focused brand activation.”
Management attributed the quarter’s results to international growth, brand innovation, and productivity initiatives, while noting margin erosion from transient costs and tariffs.
Edgewell’s outlook centers on international expansion, brand investments, and ongoing tariff and cost headwinds impacting margins and profitability.
In the quarters ahead, our team will monitor (1) the pace of international sales and market share gains, especially in Europe and Asia, (2) evidence of margin stabilization as productivity and tariff mitigation efforts take hold, and (3) the impact of increased marketing investment on brand performance and household penetration. Additionally, we will track the execution of the feminine care divestiture and supply chain consolidation initiatives as key markers for future profitability.
Edgewell Personal Care currently trades at $18.71, down from $18.91 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free for active Edge members).
Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.
The names generating the next wave of massive growth are right here in our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
| Nov-14 | |
| Nov-13 | |
| Nov-13 | |
| Nov-13 | |
| Nov-13 | |
| Nov-13 | |
| Nov-13 | |
| Nov-12 | |
| Nov-12 | |
| Nov-11 | |
| Nov-11 | |
| Nov-10 | |
| Nov-06 | |
| Nov-06 | |
| Nov-05 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite